DK1753431T3 - Farmaceutisk sammensætning omfattende ZD6474 - Google Patents

Farmaceutisk sammensætning omfattende ZD6474

Info

Publication number: DK1753431T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 2004-05-21

Application number

DK05744858T

Other languages

English (en)

Inventor

Paul William Stott

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-21

Filing date

2005-05-18

Publication date

2009-11-16

2005-05-18 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2009-11-16 Application granted granted Critical

2009-11-16 Publication of DK1753431T3 publication Critical patent/DK1753431T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

DK05744858T 2004-05-21 2005-05-18 Farmaceutisk sammensætning omfattende ZD6474 DK1753431T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0411378.3A GB0411378D0 (en)	2004-05-21	2004-05-21	Pharmaceutical compositions
PCT/GB2005/001931 WO2005112934A1 (en)	2004-05-21	2005-05-18	Pharmaceutical compositions comprising zd6474

Publications (1)

Publication Number	Publication Date
DK1753431T3 true DK1753431T3 (da)	2009-11-16

Family

ID=32607743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05744858T DK1753431T3 (da)	2004-05-21	2005-05-18	Farmaceutisk sammensætning omfattende ZD6474

Country Status (33)

Country	Link
US (1)	US8067427B2 (da)
EP (1)	EP1753431B1 (da)
JP (1)	JP4740947B2 (da)
KR (1)	KR101192935B1 (da)
CN (1)	CN101031303B (da)
AR (2)	AR049059A1 (da)
AT (1)	ATE439841T1 (da)
AU (1)	AU2005244650B2 (da)
BR (1)	BRPI0511253B8 (da)
CA (1)	CA2565513C (da)
CY (1)	CY1109500T1 (da)
DE (1)	DE602005016105D1 (da)
DK (1)	DK1753431T3 (da)
ES (1)	ES2330025T3 (da)
GB (1)	GB0411378D0 (da)
HR (1)	HRP20090547T1 (da)
IL (1)	IL178928A (da)
ME (2)	ME01505B (da)
MX (1)	MXPA06013501A (da)
MY (1)	MY138868A (da)
NO (1)	NO338324B1 (da)
NZ (1)	NZ550931A (da)
PL (1)	PL1753431T3 (da)
PT (1)	PT1753431E (da)
RS (1)	RS51112B (da)
RU (1)	RU2383343C2 (da)
SA (1)	SA05260133B1 (da)
SI (1)	SI1753431T1 (da)
TW (1)	TWI355269B (da)
UA (1)	UA81732C2 (da)
UY (1)	UY28901A1 (da)
WO (1)	WO2005112934A1 (da)
ZA (1)	ZA200609110B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2278511B1 (es) *	2005-07-28	2008-06-16	Laboratorios Almirall S.A.	Comprimidos con perfil de disolucion mejorado.
US11136625B2 (en)	2013-08-28	2021-10-05	Crown Bioscience, Inc. (Taicang)	Gene expression signatures predictive of subject response to a multi-kinase inhibitor and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
EE05330B1 (et) *	1999-11-05	2010-08-16	Astrazeneca Ab	Kinasoliini derivaadid kui VEGF-i inhibiitorid
GB0001621D0 (en) *	2000-01-26	2000-03-15	Astrazeneca Ab	Pharmaceutical compositions
KR100419555B1 (ko) *	2000-05-29	2004-02-19	주식회사유한양행	비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
GB0126879D0 (en) *	2001-11-08	2002-01-02	Astrazeneca Ab	Combination therapy
EP1481678A4 (en) *	2002-03-05	2009-12-30	Eisai R&D Man Co Ltd	ANTITUMORAL AGENT CONTAINING A SULFONAMIDE-CONTAINING HETEROCYCLIC COMPOUND AND AN ANGIOGENESIS INHIBITOR

2004
- 2004-05-21 GB GBGB0411378.3A patent/GB0411378D0/en not_active Ceased
2005
- 2005-05-09 TW TW094114935A patent/TWI355269B/zh not_active IP Right Cessation
- 2005-05-17 UY UY28901A patent/UY28901A1/es unknown
- 2005-05-18 SA SA05260133A patent/SA05260133B1/ar unknown
- 2005-05-18 PT PT05744858T patent/PT1753431E/pt unknown
- 2005-05-18 RS RSP-2009/0458A patent/RS51112B/sr unknown
- 2005-05-18 UA UAA200613289A patent/UA81732C2/ru unknown
- 2005-05-18 RU RU2006145357/15A patent/RU2383343C2/ru active Protection Beyond IP Right Term
- 2005-05-18 ME MEP-2013-50A patent/ME01505B/me unknown
- 2005-05-18 ES ES05744858T patent/ES2330025T3/es not_active Expired - Lifetime
- 2005-05-18 EP EP05744858A patent/EP1753431B1/en not_active Expired - Lifetime
- 2005-05-18 CN CN2005800162448A patent/CN101031303B/zh not_active Expired - Lifetime
- 2005-05-18 WO PCT/GB2005/001931 patent/WO2005112934A1/en not_active Ceased
- 2005-05-18 US US11/596,979 patent/US8067427B2/en active Active
- 2005-05-18 SI SI200530793T patent/SI1753431T1/sl unknown
- 2005-05-18 AT AT05744858T patent/ATE439841T1/de active
- 2005-05-18 JP JP2007517415A patent/JP4740947B2/ja not_active Expired - Lifetime
- 2005-05-18 MX MXPA06013501A patent/MXPA06013501A/es active IP Right Grant
- 2005-05-18 PL PL05744858T patent/PL1753431T3/pl unknown
- 2005-05-18 ME MEP-2009-458A patent/ME02778B/me unknown
- 2005-05-18 HR HR20090547T patent/HRP20090547T1/xx unknown
- 2005-05-18 CA CA2565513A patent/CA2565513C/en not_active Expired - Lifetime
- 2005-05-18 DK DK05744858T patent/DK1753431T3/da active
- 2005-05-18 KR KR1020067026603A patent/KR101192935B1/ko not_active Expired - Lifetime
- 2005-05-18 DE DE602005016105T patent/DE602005016105D1/de not_active Expired - Lifetime
- 2005-05-18 BR BRPI0511253A patent/BRPI0511253B8/pt active IP Right Grant
- 2005-05-18 NZ NZ550931A patent/NZ550931A/en not_active IP Right Cessation
- 2005-05-18 AU AU2005244650A patent/AU2005244650B2/en active Active
- 2005-05-19 MY MYPI20052271A patent/MY138868A/en unknown
- 2005-05-20 AR ARP050102087A patent/AR049059A1/es not_active Application Discontinuation
2006
- 2006-10-29 IL IL178928A patent/IL178928A/en active IP Right Grant
- 2006-11-01 ZA ZA200609110A patent/ZA200609110B/en unknown
- 2006-12-12 NO NO20065735A patent/NO338324B1/no not_active IP Right Cessation
2009
- 2009-10-15 CY CY20091101075T patent/CY1109500T1/el unknown
2017
- 2017-11-09 AR ARP170103128A patent/AR110045A2/es unknown

Also Published As

Publication number	Publication date
MY138868A (en)	2009-08-28
US8067427B2 (en)	2011-11-29
AR049059A1 (es)	2006-06-21
ATE439841T1 (de)	2009-09-15
KR101192935B1 (ko)	2012-10-18
CN101031303A (zh)	2007-09-05
CA2565513C (en)	2010-10-19
EP1753431B1 (en)	2009-08-19
AR110045A2 (es)	2019-02-20
HK1099220A1 (en)	2007-08-10
MXPA06013501A (es)	2007-06-12
TW200612953A (en)	2006-05-01
ME02778B (me)	2010-10-31
UA81732C2 (ru)	2008-01-25
BRPI0511253A (pt)	2007-11-27
ZA200609110B (en)	2008-06-25
RU2383343C2 (ru)	2010-03-10
BRPI0511253B8 (pt)	2021-05-25
ME01505B (me)	2014-04-20
GB0411378D0 (en)	2004-06-23
US20070244323A1 (en)	2007-10-18
JP4740947B2 (ja)	2011-08-03
AU2005244650B2 (en)	2008-04-10
CA2565513A1 (en)	2005-12-01
ES2330025T3 (es)	2009-12-03
IL178928A0 (en)	2007-03-08
BRPI0511253B1 (pt)	2020-03-31
NZ550931A (en)	2009-05-31
SA05260133B1 (ar)	2008-12-23
DE602005016105D1 (de)	2009-10-01
HRP20090547T1 (hr)	2009-11-30
UY28901A1 (es)	2005-12-30
CY1109500T1 (el)	2014-08-13
RS51112B (sr)	2010-10-31
KR20070034499A (ko)	2007-03-28
CN101031303B (zh)	2011-08-31
WO2005112934A1 (en)	2005-12-01
EP1753431A1 (en)	2007-02-21
NO338324B1 (no)	2016-08-08
AU2005244650A1 (en)	2005-12-01
PL1753431T3 (pl)	2009-12-31
TWI355269B (en)	2012-01-01
SI1753431T1 (sl)	2009-12-31
IL178928A (en)	2012-04-30
NO20065735L (no)	2006-12-19
PT1753431E (pt)	2009-10-14
RU2006145357A (ru)	2008-06-27
JP2007538060A (ja)	2007-12-27

Publication	Publication Date	Title
BRPI0511900A (pt)	2008-01-22	composições farmacêuticas
HUS1400051I1 (hu)	2016-10-28	Lurazidont tartalmazó gyógyászati készítmény
DK1940467T3 (da)	2017-02-13	Lægemiddelsammensætning med langvarig frigivelse
EP1788047A4 (en)	2011-12-21	WATER REPELLENT / OIL-REPELLING COMPOSITION
DK1725218T3 (da)	2014-09-01	Farmaceutisk sammensætning omfattende pimobendan
IL177480A0 (en)	2006-12-10	Pharmaceutical composition
DK1587478T3 (da)	2013-10-21	Farmaceutisk sammensætning
MA28801B1 (fr)	2007-08-01	Composition antihistaminique
DK2033629T3 (da)	2013-02-04	Fast farmaceutisk sammensætning omfattende valsartan
DE602005017191D1 (de)	2009-11-26	Geruchsreduzierte waschstück-zusammensetzung
HU0401177D0 (en)	2004-08-30	Pharmaceutical composition
GB2411355B (en)	2006-02-22	Pharmaceutical composition
EP1937255A4 (en)	2013-06-26	PHARMACEUTICAL COMPOSITION
MA28603B1 (fr)	2007-05-02	Composition pharmaceutique antimycobacterienne
EP1862184A4 (en)	2012-12-19	PHARMACEUTICAL COMPOSITION
FR2871686B1 (fr)	2008-02-29	Composition anti-decoloration
GB0425255D0 (en)	2004-12-15	Pharmaceutical composition
ZA200701932B (en)	2008-08-27	Pharmaceutical composition
ITMI20041447A1 (it)	2004-10-20	Composizione farmaceutica comprendente gabapentina
BRPI0614413A2 (pt)	2016-11-22	composto, e, composição farmacêutica
ITMI20040943A1 (it)	2004-08-11	Composizione farmaceutica cicatrizzante
BRPI0614412A2 (pt)	2016-11-22	composto, e, composição farmacêutica
ZA200701931B (en)	2008-10-29	Pharmaceutical composition
DK1753431T3 (da)	2009-11-16	Farmaceutisk sammensætning omfattende ZD6474
NO20042027D0 (no)	2004-05-14	Oral composition